Q2 FY2026 · ended Jun 30, 2026 · Revenue $972.52M, +48.5% YoY · Filed Aug 10, 2026
Astrana Health, Inc. (ASTH) files with the SEC under industry code 8742, Services-Management Consulting Services. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $972.5 million and net income of $19.7 million. Free cash flow was $92.9 million. As of Jun 30, 2026 it held $402.1 million in cash and investments and $979.4 million in total debt.
Revenue
$972.52M
+48.5% vs year-ago quarter
Net income
$19.74M
+109.5% vs year-ago quarter
Operating cash flow
$100.80M
+10.9% vs year-ago quarter
Free cash flow
$92.93M
+3.8% vs year-ago quarter
EPS
$0.40
+110.5% vs year-ago quarter
Dividend per share
None
Shares outstanding
55.74M
-0.6% vs year-ago quarter
Net cash
$-577.27M
Q2 FY2026
Operating margin
2.6%
TTM
Company profile
- Industry
- Services-Management Consulting Services (SIC 8742)
- Listed as
- ASTH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Alhambra, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1083446
- Former names
- Apollo Medical Holdings, Inc. (until Feb 13, 2024); SICLONE INDUSTRIES INC (until Jul 15, 2008)
Other Services-Management Consulting Services companies
- Cgi Inc GIB
- Booz Allen Hamilton Holding Corp BAH
- Genpact LTD G
- Fti Consulting, Inc FCN
- Exponent Inc EXPO
- Huron Consulting Group Inc. HURN
- ICF International, Inc. ICFI
- Bowman Consulting Group Ltd. BWMN
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
Q1 FY2025 Mar 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $972.5M | $950.5M | $956.0M | $654.8M | $620.4M |
| Operating income | $34.3M | $18.4M | $19.2M | $20.3M | $20.6M |
| Net income | $19.7M | $6.0M | $373,000 | $9.4M | $6.7M |
| Diluted EPS | $0.40 | $0.12 | $0.01 | $0.19 | $0.14 |
| Operating cash flow | $100.8M | -$2.9M | $10.0M | $90.9M | $16.6M |
| Free cash flow | $92.9M | -$6.0M | $7.4M | $89.5M | $13.6M |
| Total assets | $2.3B | $2.2B | $2.2B | $1.4B | $1.3B |
| Total liabilities | $1.7B | $1.7B | $1.7B | $904.4M | $813.5M |
| Stockholders' equity | $830.2M | $779.3M | $775.5M | $765.5M | $745.4M |
| Cash and investments | $402.1M | $429.6M | $463.4M | $342.1M | $260.9M |
| Total debt | $979.4M | $1.1B | $1.1B | $447.6M | $451.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 23, 2026 | Sep 23, 2026 |
| 8-K | Current report | Sep 23, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2026 | Sep 15, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 13, 2026 | Jul 13, 2026 |
All 1000 Astrana Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.